These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 20862710

  • 1. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
    Liu Y, Hock JM, Sullivan C, Fang G, Cox AJ, Davis KT, Davis BH, Li X.
    J Cell Biochem; 2010 Dec 15; 111(6):1546-55. PubMed ID: 20862710
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ, Smith MF, Goldberg JB.
    J Gastroenterol Hepatol; 2008 Jul 15; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [Abstract] [Full Text] [Related]

  • 3. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2.
    Binet F, Girard D.
    J Leukoc Biol; 2008 Dec 15; 84(6):1613-22. PubMed ID: 18728151
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ, Kim KW.
    Invest Ophthalmol Vis Sci; 2009 Apr 15; 50(4):1819-23. PubMed ID: 19060284
    [Abstract] [Full Text] [Related]

  • 5. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis.
    Parekh P, Rao KV.
    Cell Biol Int; 2007 Jan 22; 31(1):35-43. PubMed ID: 17055752
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM, Brokken LJ, Härkönen PL.
    Exp Cell Res; 2010 Mar 10; 316(5):800-12. PubMed ID: 19962979
    [Abstract] [Full Text] [Related]

  • 8. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
    Ouyang W, Li J, Zhang D, Jiang BH, Huang DC.
    J Cell Biochem; 2007 Jul 01; 101(4):969-78. PubMed ID: 17370311
    [Abstract] [Full Text] [Related]

  • 9. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY, Small GW, Orlowski RZ.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):33-47. PubMed ID: 16807678
    [Abstract] [Full Text] [Related]

  • 10. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH.
    Anticancer Res; 2009 Oct 01; 29(10):3837-44. PubMed ID: 19846917
    [Abstract] [Full Text] [Related]

  • 11. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.
    Riuzzi F, Sorci G, Donato R.
    J Cell Physiol; 2006 May 01; 207(2):461-70. PubMed ID: 16419039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS, Chen C, Berry JE, McCauley LK.
    J Bone Miner Res; 2005 Jun 01; 20(6):1051-64. PubMed ID: 15883646
    [Abstract] [Full Text] [Related]

  • 14. The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytes.
    Mudipalli A, Owen RD, Preston RJ.
    Int J Oncol; 2005 Sep 01; 27(3):769-78. PubMed ID: 16077927
    [Abstract] [Full Text] [Related]

  • 15. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC.
    Endocr Relat Cancer; 2007 Jun 01; 14(2):513-29. PubMed ID: 17639064
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways.
    Yang XS, Liu S, Liu YJ, Liu JW, Liu TJ, Wang XQ, Yan Q.
    J Cell Physiol; 2010 Nov 01; 225(2):612-9. PubMed ID: 20506505
    [Abstract] [Full Text] [Related]

  • 17. High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways.
    Ryu JM, Lee MY, Yun SP, Han HJ.
    J Cell Physiol; 2010 Jul 01; 224(1):59-70. PubMed ID: 20232305
    [Abstract] [Full Text] [Related]

  • 18. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC, Teng CM, Lin SL, Chen YM, Tsai TJ, Hsieh BS.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):1-10. PubMed ID: 15950964
    [Abstract] [Full Text] [Related]

  • 19. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
    Chiou WF, Tsai HR, Yang LM, Tsai WJ.
    Int Immunopharmacol; 2004 Oct 04; 4(10-11):1329-41. PubMed ID: 15313431
    [Abstract] [Full Text] [Related]

  • 20. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK, Li K, Chik KW, Yang M, Liu VC, Li CK, Fok TF, Ng PC, Shing MM, Chuen CK, Yuen PM.
    Int J Oncol; 2005 Aug 04; 27(2):537-45. PubMed ID: 16010437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.